Results

1–5 of 5 results for Benefit

Economic Benefit of Higher Durability Anti-VEGF Agents in the Treatment of Neovascular Macular Degeneration
Sabin Dang, MD
Annual Meeting Talks
2023
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2022
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Uncertain Benefit of Vitrectomy for Post-Injection Endophthalmitis in Age-Related Macular Degeneration
Mark R. Barakat, MD
On Demand Cases, Courses, and Papers
2017
Clinical Benefits of 27-Gauge High-Speed Dual-Pneumatic Vitrectomy: A Prospective, Multicenter Randomized Controlled Trial
Steve T Charles, MD FASRS FACS FICS
On Demand Cases, Courses, and Papers
2017